Markets › United States › NYSE › WST

West Pharmaceutical Services Inc

NYSE:WSTHealthcareNASDAQ:NQUSMGSTOXX:EDD24BP

$383.91−0.03%At closeAt close · Tue 20 Oct · ≈ AED 1,409.91 · Market cap $27.02B · Next earnings Thu 22 Oct

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	35.8%	41.5%	39.5%	38.4%	34.6%	35.9%	—	—
Operating margin	19.5%	26.8%	26.5%	24.1%	20.6%	20.1%	20.1%	+0.0 pts
Net margin	16.1%	23.4%	20.3%	20.1%	17.0%	16.1%	16.1%	+0.0 pts
EBITDA margin	24.2%	31.1%	28.0%	28.6%	25.7%	23.5%	—	—
Return on equity	18.7%	28.3%	21.8%	20.6%	18.4%	15.5%	15.5%	+0.0 pts
Return on assets	12.4%	20.0%	16.2%	15.5%	13.5%	11.6%	11.6%	+0.0 pts
Return on capital employed	18.3%	27.9%	24.6%	22.5%	19.2%	17.1%	—	—
Debt / equity	0.2×	0.1×	0.1×	0.1×	0.1×	0.1×	0.1×	+0.0%
Debt / assets	11.7%	9.8%	8.8%	8.1%	8.4%	9.8%	—	—
Interest coverage	49.3×	89.3×	100.5×	80.8×	205.0×	1,029.0×	—	—
Current ratio	2.7×	2.9×	3.7×	2.9×	2.8×	3.0×	3.0×	+0.0%
Quick ratio	2.1×	2.3×	2.9×	2.2×	2.1×	2.3×	—	—
Cash ratio	1.2×	1.3×	1.7×	1.3×	0.9×	1.2×	1.2×	+0.0%
Asset turnover	0.8×	0.9×	0.8×	0.8×	0.8×	0.7×	—	—
Inventory turnover	4.3×	4.4×	4.2×	4.2×	5.0×	4.4×	—	—
Receivables turnover	5.6×	5.8×	5.7×	5.8×	5.2×	5.4×	—	—
Dividend payout	13.9%	7.7%	9.2%	9.6%	12.0%	12.4%	—	—